Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 42743714

Differential DNA damage vulnerability in human neuropathies.

Sai-Sai Xue·Guocui Cai·Zhao-Qi Wang
View original source ↗Export metadata ↓

Abstract

The maintenance of genomic integrity is a fundamental prerequisite for tissue homeostasis, which is critical for central nervous system (CNS) function. During neurogenesis, the transition from rapidly proliferating neuroprogenitors to post-mitotic neurons entails a fundamental shift in genotoxic threats, which must be addressed by the robust DNA damage response (DDR) network. The spatiotemporal utilisation of distinct DDR pathways in different neural cell types establishes heterogeneous vulnerabilities in specific brain regions to pathological processes. While the cerebrum exhibits varying or negligible degrees of sensitivity to DDR defects, cerebellar atrophy and degeneration are common hallmarks of various human genomic instability syndromes (GIS). Biomedical and cellular studies of human GIS and the corresponding mouse models have shed light on the aetiology of the associated neuropathies; however, cerebellar vulnerability to DDR defects remains poorly understood. Here, we review the cell type- and species-specific divergences in DDR reliance in different brain regions, along with the corresponding DDR pathways underpinning the distinct susceptibility of neuropathological manifestations.

Explore related subjects

Animal modelCellular heterogeneityDNA damage responseDNA repairGenomic instability syndromeNeuropathyJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Sai-Sai Xue, Guocui Cai, Zhao-Qi Wang. 2026-09-13. Differential DNA damage vulnerability in human neuropathies.. https://doi.org/10.1016/j.dnarep.2026.103959

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

Kefir and Its By-Products Supplementation Reduces Inflammation and Oxidative Stress, Improves Intestinal Barrier Integrity, and Modulates the Gut Microbiota in Animal Models of Inflammatory Bowel Disease: A Systematic Review.

UNLABELLED: Kefir is a beverage obtained by fermenting milk or sugary solutions with a symbiotic community of bacteria and yeasts, presenting promising antimicrobial, antioxidant, and immunomodulatory properties. This systematic review aimed to synthesize evidence from preclinical studies evaluating the effects of kefir or its by-products on biomarkers of inflammation, oxidative stress, and gut health in animal models of IBD. A systematic review was conducted in accordance with PRISMA guidelines, utilizing the PubMed/MEDLINE, Web of Science, Embase, and Scopus databases. The quality of the studies was assessed using SYRCLE’s Risk of Bias tool. Sixteen experimental studies were included, comprising 585 rodents with chemically induced colitis. The interventions included traditional milk kefir, rice and water kefir, as well as isolated microorganisms and kefir-derived supernatants. Most studies reported reductions in inflammatory cytokines (TNF-α, IL-1β, IL-6) and inflammatory enzymes (iNOS, COX-2, MPO), along with increases in anti-inflammatory cytokines (IL-10, IL-4). Reductions in MDA and H₂O₂ were reported, supporting the antioxidant effects of kefir and its derivatives. Changes in antioxidant enzyme activity, including SOD, were also observed. In addition, kefir modulated gut microbiota composition, upregulated the expression of tight junction proteins, and influenced immune and molecular signaling pathways. Improvements were also observed in clinical parameters of IBD models, including disease activity index, rectal bleeding, and histological damage. Kefir and its derivatives exhibit beneficial effects on inflammation, oxidative stress, gut permeability, and immune modulation in animal models of IBD, suggesting a potential alternative for treating these diseases in humans. Although the findings are promising, heterogeneity among study protocols and methodological limitations highlight the need for further studies. Registration PROSPERO number: CRD420251062931. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at https://doi.org/10.1007/s12602-026-10948-5.

Animal model↗